3. Anstee DJ, Tanner MJ. Biochemical aspects of the blood group Rh (rhesus) antigens. Baillieres Clin Haematol 1993;6:401-22.
4. Liumbruno GM, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus 2013;11:491-9.
5. Franchini M, Mengoli C, Lippi G. Relationship between ABO blood group and pregnancy complications: a systematic literature analysis. Blood Transfus 2016;14:441-8.
6. Yu H, Xu N, Li ZK, Xia H, Ren HT, Li N, et al. Association of ABO blood groups and risk of gastric cancer. Scand J Surg 2019;1457496919863886.
7. Paquette M, Dufour R, Baass A. ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia. J Clin Lipidol 2018 12:383-389. e1.
8. Witsenburg CP, Rosendaal FR, Middeldorp JM, Van der Meer FJ, Scherjon SA. Factor VIII levels and the risk of pre-eclampsia, HELLP syndrome, pregnancy related hypertension and severe intrauterine growth retardation. Thromb Res 2005;115:387-92.
9. Seyfizadeh N, Seyfizadeh N, Yousefi B, Borzoueisileh S, Majidinia M, Shanehbandi D, et al. Is there association between ABO blood group and the risk factors of unfavorable outcomes of pregnancy? J Matern Fetal Neonatal Med 2015;28:578-82.
10. Duerbeck NB, Seeds JW. Rhesus immunization in pregnancy: a review. Obstet Gynecol Surv 1993;48:801-10.
13. Scott JR, Beer AA. Immunologic aspects of pre-eclampsia. Am J Obstet Gynecol 1976;125:418-27.
14. Finning K, Martin P, Summers J, Daniels G. Fetal genotyping for the K (Kell) and Rh C, c, and E blood groups on cell-free fetal DNA in maternal plasma. Transfusion 2007;47:2126-33.
15. Andersen AS, Praetorius L, Jørgensen HL, Lylloff K, Larsen KT. Prognostic value of screening for irregular antibodies late in pregnancy in rhesus positive women. Acta Obstet Gynecol Scand 2002;81:407-11.
17. Kobets TV, Usachenko IE. Risk factors of complicated postnatal period in low birth weight infants. Tsitol Genet 2001;35:49-53.
19. Zipursky A, Bhutani VK, Odame I. Rhesus disease: a global prevention strategy. Lancet Child Adolesc Health 2018;2:536-42.
20. Bel Hadj I, Boukhris R, Khalsi F, Namouchi M, Bougmiza I, Tinsa F, et al. ABO hemolytic disease of newborn : does newborn’s blood group a risk factor? Tunis Med 2019;97:455-60.
22. Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066-74.
23. May D. Letter: Maternal blood group A and pre-eclampsia. BMJ 1973;4:738.
24. Lee BK, Zhang Z, Wikman A, Lindqvist PG, Reilly M. ABO and RhD blood groups and gestational hypertensive disorders: a population-based cohort study. BJOG 2012;119:1232-7.
25. Chen Y, Chen C, Ke X, Xiong L, Shi Y, Li J, et al. Analysis of circulating cholesterol levels as a mediator of an association between ABO blood group and coronary heart disease. Circ Cardiovasc Genet 2014;7:43-8.
27. Smits-Wintjens VE, Walther FJ, Lopriore E. Rhesus haemolytic disease of the newborn: postnatal management, associated morbidity and long-term outcome. Semin Fetal Neonatal Med 2008;13:265-71.